Text-based Support for Parents of Adolescents Following an Emergency Department Visits (TESP)

December 12, 2025 updated by: Ewa Czyz, University of Michigan

Effectiveness of Text-based Support for Parents of Suicidal Adolescents Following Emergency Department Visits

The goal of this study is to determine the effectiveness of an adaptive text-based intervention for parents of adolescents seeking emergency department services for suicide risk concerns.

Study Overview

Status

Recruiting

Conditions

Intervention / Treatment

Detailed Description

Participants will be 420 adolescents (ages 13-17) seen in ED with recent suicidal ideation and/or attempt and their parents recruited from two health system EDs in the Midwest.

Study Type

Interventional

Enrollment (Estimated)

420

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

  • Name: Ewa Czyz, Ph.D.
  • Phone Number: 734-764-9466
  • Email: ewac@umich.edu

Study Locations

    • Michigan
      • Ann Arbor, Michigan, United States, 48109
        • Recruiting
        • University of Michigan
        • Principal Investigator:
          • Ewa Czyz, PhD
        • Contact:
      • Flint, Michigan, United States, 48503
        • Recruiting
        • Hurley Medical Center
        • Contact:
        • Principal Investigator:
          • Courtney Mangus, M.D.

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Adolescent (13-17 years old) who present to Emergency Department (ED) due to (1) last-week suicidal ideation and/or (2) last-month suicide attempt, and their caregiver.

Exclusion Criteria:

Adolescents who are:

  • medically unstable
  • presenting with severe cognitive impairment, altered mental status, severe aggression/agitation
  • presenting without a legal guardian
  • whose parent does not own a cell phone

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
No Intervention: Standard ED care
Experimental: Standard ED care with a text-based intervention

This arm incorporates adolescent-centered (A-C) and parent-centered (P-C) texting components

Parents in the intervention arm will receive up to 3 text messages per day over six weeks after ED discharge: daily A-C text and up to two P-C messages. The P-C component includes an embedded micro-randomized trial (MRT), and parents will be randomized twice each day over the six-week intervention to either receive or not receive a P-C message.

Parents randomized to the texting intervention will receive up to 3 messages each day for 6 weeks: The intervention is comprised of adolescent-centered (A-C) texts focusing on parental adherence to recommended suicide prevention strategies to promote adolescents' safety and parent-centered (P-C) texts focused on improving parents' own well-being.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Aim 1 (primary aim): likelihood of suicidal behavior (actual, interrupted, or aborted attempts)
Time Frame: 12-week follow-up
Suicidal behavior encompasses actual, interrupted, and aborted suicide attempts. Measured with the behavioral subscale of the Columbia-Suicide Severity Rating Scale (C-SSRS),and supplemented with available medical chart data.
12-week follow-up
Aim 2 (secondary aim) severity of parental stress
Time Frame: Up to 6 weeks
Measured with twice daily surveys over the 6-week intervention
Up to 6 weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Aim 1 (primary aim): -time- to- suicidal behavior (actual, interrupted, or aborted suicide attempts
Time Frame: 24-week follow-up
Measured with the behavioral subscale of C-SSRS and supplemented with available chart data.
24-week follow-up
Aim 1 (primary aim): time- to- return ED visit
Time Frame: 24-week follow-up.
24-week follow-up.
Aim 2 (secondary aim): parental negative affect
Time Frame: Up to 6 weeks
Measured with twice daily surveys over the 6-week intervention.
Up to 6 weeks
Aim 2 (secondary aim) parental positive affect
Time Frame: Up to 6 weeks
Measured with twice daily surveys over the 6-week intervention.
Up to 6 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Ewa Czyz, Ph.D., University of Michigan

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

December 1, 2025

Primary Completion (Estimated)

July 1, 2028

Study Completion (Estimated)

July 1, 2028

Study Registration Dates

First Submitted

October 23, 2024

First Submitted That Met QC Criteria

October 23, 2024

First Posted (Actual)

October 28, 2024

Study Record Updates

Last Update Posted (Actual)

December 15, 2025

Last Update Submitted That Met QC Criteria

December 12, 2025

Last Verified

December 1, 2025

More Information

Terms related to this study

Other Study ID Numbers

  • HUM00254540
  • 1R01MH137012-01 (U.S. NIH Grant/Contract)

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Suicide

Clinical Trials on Text-based intervention

Subscribe